Latest & greatest articles for epilepsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on epilepsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on epilepsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for epilepsy

41. Current prevalences and their proportions of anxiety disorders in epilepsy clinics for routine care: a meta-analysis

Current prevalences and their proportions of anxiety disorders in epilepsy clinics for routine care: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

42. Anti-epileptic medication non-adherence and associated factors among adults with epilepsy treatment in Ethiopia: a systematic review and meta analysis

Anti-epileptic medication non-adherence and associated factors among adults with epilepsy treatment in Ethiopia: a systematic review and meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

43. Antiepileptic drugs for the management of epilepsy in children under 5 years with tuberous sclerosis complex [Cochrane protocol]

Antiepileptic drugs for the management of epilepsy in children under 5 years with tuberous sclerosis complex [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

44. The use of ketogenic diets in infants with epilepsy: a systematic review

The use of ketogenic diets in infants with epilepsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

45. Statins for the prevention of post-stroke seizure and epilepsy development: a systematic review

Statins for the prevention of post-stroke seizure and epilepsy development: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

46. Cannabidiol for epilepsy in adults: a systematic review

Cannabidiol for epilepsy in adults: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

47. Antibody testing in epilepsy

Antibody testing in epilepsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

48. The effectiveness of anti-epileptic therapies for epilepsy with myoclonic astatic seizures (Doose syndrome)

The effectiveness of anti-epileptic therapies for epilepsy with myoclonic astatic seizures (Doose syndrome) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

49. Effectiveness of epilepsy nurse specialist

Effectiveness of epilepsy nurse specialist Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

50. The safety of different doses of brivaracetam and levetiracetam in patients with epilepsy: a Bayesian based network meta-analysis of randomized trials

The safety of different doses of brivaracetam and levetiracetam in patients with epilepsy: a Bayesian based network meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

51. The use of folic acid during periconceptional period in patients with epilepsy: a systematic review

The use of folic acid during periconceptional period in patients with epilepsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

52. Computed tomography (CT) scan performance in people with epilepsy

Computed tomography (CT) scan performance in people with epilepsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

53. Determine the risk of motor vehicle crashes for drivers with epilepsy and/or seizures

Determine the risk of motor vehicle crashes for drivers with epilepsy and/or seizures Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

54. Long-term seizure outcome in frontal lobe epilepsy surgery and predictors of seizure freedom: a systematic review and meta-analysis

Long-term seizure outcome in frontal lobe epilepsy surgery and predictors of seizure freedom: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

55. Magnetic resonance imaging scanning to detect relevant abnormalities in people with epilepsy

Magnetic resonance imaging scanning to detect relevant abnormalities in people with epilepsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

56. A systematic review of functional interference studies in experimental model for Temporal Lobe Epilepsy.

A systematic review of functional interference studies in experimental model for Temporal Lobe Epilepsy. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

57. Effect of the ketogenic diet on cognition and markers and neuroplasticity in refractory epilepsy: a systematic review

Effect of the ketogenic diet on cognition and markers and neuroplasticity in refractory epilepsy: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

58. Assessing the effectiveness of magnetic resonance guided laser interstitial thermal therapy among patients with medically intractable epilepsy: a systematic review and meta-analysis

Assessing the effectiveness of magnetic resonance guided laser interstitial thermal therapy among patients with medically intractable epilepsy: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

59. The interface between temporal lobe epilepsy and symptoms of depression: a systematic review

The interface between temporal lobe epilepsy and symptoms of depression: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

60. Association between Helicobacter pylori infection and epilepsy : a systematic review and meta-analysis

Association between Helicobacter pylori infection and epilepsy : a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO